A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Vaccine

• Publication date

  2009-01-07

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.vaccine.2008.10.046PMID 18996430PMCID PMC2651515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation

  2008cited by this paper
• A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.

  2007cited by this paper
• Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus

  2007cited by this paper
• A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.

  2007cited by this paper
• Immunization of Flavivirus West Nile Recombinant Envelope Domain III Protein Induced Specific Immune Response and Protection against West Nile Virus Infection1

  2007cited by this paper
• Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.

  2007cited by this paper
• Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.

  2007cited by this paper
• West Nile virus: recent trends in diagnosis and vaccine development.

  2007cited by this paper
• Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.

  2007influential reference
• Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.

  2007cited by this paper
• Crystal Structure of the West Nile Virus Envelope Glycoprotein

  2006cited by this paper
• Vaccines for Viral and Parasitic Diseases Produced with Baculovirus Vectors

  2006cited by this paper
• Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.

  2006cited by this paper
• A live, attenuated recombinant West Nile virus vaccine.

  2006cited by this paper
• A single immunization with a minute dose of a lentiviral vector‐based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus

  2006cited by this paper
• Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes

  2006influential reference
• Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells

  2005cited by this paper
• An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.

  2005cited by this paper
• Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.

  2005cited by this paper
• A recombinant envelope protein vaccine against West Nile virus.

  2005influential reference
• Structure of the dengue virus envelope protein after membrane fusion

  2004cited by this paper
• ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy

  2004cited by this paper
• West Nile virus: a growing concern?

  2004cited by this paper
• Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells.

  2004cited by this paper
• Aluminium compounds for use in vaccines

  2004cited by this paper
• The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.

  2004cited by this paper
• Detection of Human Anti-Flavivirus Antibodies with a West Nile Virus Recombinant Antigen Microsphere Immunoassay

  2004cited by this paper
• Chimpanzee Fab Fragments and a Derived Humanized Immunoglobulin G1 Antibody That Efficiently Cross-Neutralize Dengue Type 1 and Type 2 Viruses

  2004cited by this paper
• Equine vaccine for West Nile virus.

  2003influential reference
• Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.

  2003cited by this paper
• West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

  2002cited by this paper
• West Nile Virus

  2002cited by this paper
• Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

  2001cited by this paper
• Immunization of Mice Against West Nile Virus with Recombinant Envelope Protein1

  2001cited by this paper
• West Nile encephalitis: an emerging disease in the United States.

  2001cited by this paper
• West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

  2001cited by this paper
• West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis.

  2001cited by this paper
• Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut.

  1999cited by this paper
• Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.

  1991cited by this paper

• Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development

  2023cites this paper
• Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection

  2023cites this paper
• “Review On West Nile Virus Disease: Its Outbreak And Current Status”

  2021cites this paper
• Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies

  2021cites this paper
• Comparative Pathology of West Nile Virus in Humans and Non-Human Animals

  2020cites this paper
• West Nile Virus

  2016cites this paper
• An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection

  2016cites this paper
• A Brief Review of West Nile Virus Biology.

  2016cites this paper
• Recombinant protein subunit vaccine synthesis in microbes: a role for yeast?

  2015cites this paper
• Technologies for the development of West Nile virus vaccines.

  2014cites this paper
• A Recombinant Novirhabdovirus Presenting at the Surface the E Glycoprotein from West Nile Virus (WNV) Is Immunogenic and Provides Partial Protection against Lethal WNV Challenge in BALB/c Mice

  2014cites this paper
• Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.

  2014cites this paper
• Industrial Large Scale of Suspension Culture of Insect Cells

  2014cites this paper
• Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro.

  2014cites this paper
• Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.

  2013cites this paper
• West Nile Virus: 12 Years in North America

  2013cites this paper
• Vaccines in Development against West Nile Virus

  2013cites this paper
• C-Terminal Helical Domains of Dengue Virus Type 4 E Protein Affect the Expression/Stability of prM Protein and Conformation of prM and E Proteins

  2012cites this paper
• Research advances in plant-made flavivirus antigens.

  2012cites this paper
• West Nile virus: A re-emerging pathogen revisited.

  2012cites this paper
• Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age.

  2012cites this paper
• Immunization of West Nile recombinant envelope Domain III with equine CD40 ligand protein vaccine induced specific immune response in rabbits and horses

  2012cites this paper
• Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.

  2011cites this paper
• Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system.

  2011cites this paper
• Insect cell technology is a versatile and robust vaccine manufacturing platform

  2011cites this paper
• Detection and molecular epidemiology of tick-borne encephalitis virus infections

  2011cites this paper
• Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.

  2011cites this paper
• A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus

  2011cites this paper
• West Nile Encephalitis as Immunization Vectors Protect against TLR9-Targeted Biodegradable Nanoparticles

  2010cites this paper
• West Nile Virus: is a vaccine needed?

  2010cites this paper
• Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae.

  2010cites this paper
• Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.

  2010cites this paper
• Fine-specificity and functional quality of the antibody response in mice to whole inactivated West Nile virus and recombinant subunit antigens

  2010influential citation
• Nile Encephalitis Westas Immunization Vectors Protect against TLR 9-Targeted Biodegradable Nanoparticles Data

  2010cites this paper
• TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis

  2010cites this paper
• A purified recombinant baculovirus expressed capsid protein of a new astrovirus provides partial protection to runting–stunting syndrome in chickens

  2009cites this paper
• Tlr9-targeted Biodegradable Nanoparticles

  year unknowncites this paper